|
Jul 29
|
Wall Street is still jittery on GLP-1s
|
|
Jul 29
|
Prediction: This Will Be Pfizer's Next Big Move
|
|
Jul 29
|
Big Pharma Rallies and Moves Past Obesity
|
|
Jul 29
|
RSV vaccine makers vying for market share in second year of shots
|
|
Jul 29
|
3 Ultra-High-Yield Dividend Stocks to Buy Now and Hold Forever
|
|
Jul 28
|
2 Incredibly Cheap Healthcare Stocks to Buy Now
|
|
Jul 27
|
2 High-Yield Dividend Stocks That Could Shine in 2025
|
|
Jul 27
|
2 Unstoppable Growth Stocks to Buy Right Now for Less Than $200
|
|
Jul 26
|
Big Tech earnings, jobs report, Fed decision: What to Watch
|
|
Jul 26
|
Pharma Stock Roundup: AZN, SNY, ABBV Q2 Earnings, PFE & MRK's Positive Pipeline News
|
|
Jul 26
|
Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know
|
|
Jul 26
|
EC conditionally approves Pfizer’s haemophilia B gene therapy
|
|
Jul 26
|
This Biotech Risk-Taker Created Moderna. Now He’s Harnessing AI.
|
|
Jul 25
|
How To Earn $100 Per Month From Pfizer Stock
|
|
Jul 25
|
European Commission Approves Pfizer’s DURVEQTIX® (fidanacogene elaparvovec), a One-Time Gene Therapy for Adults with Hemophilia B
|
|
Jul 25
|
Patience Could Be Rewarded With Moat Investing
|
|
Jul 25
|
Seeking Clues to Pfizer (PFE) Q2 Earnings? A Peek Into Wall Street Projections for Key Metrics
|
|
Jul 25
|
3 Stocks That Can Help You to Get Richer in 2024 and Beyond
|
|
Jun 24
|
Britain snubs GSK in favour of US pharma giant for RSV vaccine
|
|
Jun 24
|
Alnylam Soars After Drug Meets Goal in Heart Disease Trial
|